2021 IPO
Rani Therapeutics Stock
Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.
Sign up today and learn more about Rani Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Rani Therapeutics Stock
Rani Therapeutics, LLC develops a oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies. The company is based in San Jose, California.
Funding History
| June 2012 | $4.0M |
|---|---|
| July 2013 | $9.4M |
| May 2015 | $37.1M |
| September 2017 | $39.0M |
| February 2018 | $53.0M |
Management
Vice President, Finance & Operations
Syed Zaidi
Vice President, Research & Development
Mir Hashim
Founder, Chairman & CEO
Mir Imran
Vice President, Operations
Bob Gaffney
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
